FDA-Drug2026-07-29Class IICHEMICAL

Major Pharmaceuticals levothyroxine 25 mcg tablets recalled for subpotency

LABEL MIX UPNationwide distributionDrugs

What this means

Major Pharmaceuticals levothyroxine sodium 25 mcg tablets in certain lots do not contain the full labeled amount of active ingredient. This means the medication may not work as intended to treat thyroid conditions. The affected lots (N02212A, N02212B, and blister lot N02212, all expiring 07/2026) were distributed nationwide.

  • Check if your levothyroxine matches the affected lot numbers and NDC codes listed (carton 55154-3558-0 or blister 0904-6949-61).
  • Do not stop taking your medication without talking to your doctor.
  • Contact your pharmacy or doctor if you have questions about whether your supply is affected.
  • Report any changes in your thyroid symptoms to your healthcare provider.
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Carton: 55154-3558-0; NDC Blister: 0904-6949-61

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0707-2026

More Major Pharmaceuticals recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime